Viewing Study NCT02021318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-02-26 @ 12:03 PM
Study NCT ID: NCT02021318
Status: COMPLETED
Last Update Posted: 2024-11-14
First Post: 2013-12-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia in Chronic Kidney Disease in Non-dialysis Patients View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-dialysis View
None Roxadustat View
None ASP1517 View
None Chronic Kidney Disease (CKD) View
None Anemia View
None Hemoglobin View